Importantly, in Gli1-deficient SHH MB cells, where p21 is upregulated and tumor cell growth is inhibited compared to controls, mocetinostat is unable to cause any further increase of p21 or inhibition of cell growth. The gene discussed is GLI1; the disease is neoplasm.